Scholar Rock Holding (SRRK) Interest Expenses (2024 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Interest Expenses of $2.3 million in Q1 2026, down 9.16% quarter-over-quarter from $2.5 million in Q4 2025, and up 26.62% on a YoY basis from $1.8 million in Q1 2025.
Scholar Rock Holding (SRRK) Interest Expenses (2024 - 2026) Analysis & Trends
Scholar Rock Holding's Interest Expenses history runs 3 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 26.62% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $7.4 million (up 6.54% YoY), while the FY2025 annual figure was $6.9 million, up 0.82% from the prior year.
- Interest Expenses was $2.3 million for Q1 2026 at Scholar Rock Holding, down from $2.5 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $2.5 million in Q4 2025 to a low of $1.2 million in Q2 2025.
- Historically, Interest Expenses has averaged $1.8 million across 3 years, with a median of $1.7 million in 2024.
- Biggest YoY gain for Interest Expenses was 53.95% in 2025; the steepest drop was 29.68% in 2025.
- A 3-year view of Interest Expenses shows it stood at $1.6 million in 2024, then surged by 53.95% to $2.5 million in 2025, then decreased by 9.16% to $2.3 million in 2026.
- The last three Interest Expenses figures came in at $2.3 million (Q1 2026), $2.5 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 2.53 Mn |
| Dec 31, 2025 | 2.53 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.73 Mn |